Roche (@Roche) / X

Roche

14.8K posts

Roche

@Roche

We advance science so that we all have more time with the people we love. Read our community guidelines: go.roche.com/CG

Basel, Switzerland

Joined February 2009

Roche
@Roche
Jul 20
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation go.roche.com/xnanosbx
Roche
@Roche
Jul 15
#MEDIA – We are pleased to announce that the U.S. FDA has accepted Roche’s supplemental Biologics License Application, with priority review, in primary #MembranousNephropathy Read more here 👉 spkl.io/60167yjsi $ROG $RHHBY
Roche
@Roche
Jul 14
The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. roche.com/media $RHHBY $ROG Available in countries accepting the
Roche
@Roche
Jul 12
We're at #AAIC26! Come by booth to speak to our team about the latest advancements in Alzheimer’s. We look forward to meeting you! 👋
Roche
@Roche
Jul 9
Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer to global TB elimination. 🌍
Roche
@Roche
Jul 7
#MEDIA – We are pleased to share that Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at #AAIC26. Learn more 👉 roche.com/media
Roche
@Roche
Jul 2
#MEDIA We are pleased to share that our Phase III study in advanced #KRAS G12C-positive #NSCLC met its primary endpoint, demonstrating positive top-line results. Read more here: roche.com/media/releases
Roche
@Roche
Jun 30
The Bundibugyo virus is a rare and deadly strain of #Ebola that often escapes detection by commonly used frontline tests. That’s why containing outbreaks while providing critical surveillance to monitor any further spread is vital. Our commitment to reinforcing healthcare
Roche
@Roche
Jun 30
#MEDIA - We are pleased that the US FDA has accepted the supplemental Biologics License Application (sBLA) for our investigational medicine for thyroid eye disease (TED). 👉 roche.com/media
Roche
@Roche
Jun 29
#MEDIA - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research workflows, demonstrating end‑to‑end whole‑genome results within hours. roche.com/media/releases #Genomics #HumanGenetics #RocheSBX #Innovation #NGS
Roche
@Roche
Jun 18
#MEDIA – We are pleased to announce that the US FDA has accepted Roche’s supplemental Biologics License Application for a new bispecific antibody combination treatment for people with relapsed or refractory large B-cell lymphoma (#LBCL). #Lymphoma #BCELL 🔗
Roche
@Roche
Jun 12
As the @EHA_Hematology Congress (#EHA2026) kicks off, hear from Steve Tuplin, Haematology Franchise Head at Roche, on our commitment to exploring combination approaches that advance B-cell malignancy outcomes. 👇
Roche
@Roche
Jun 2
#MEDIA – We are pleased that the US FDA has accepted the New Drug Application for our investigational medicine in ER-positive early-stage #BreastCancer in the adjuvant setting spkl.io/6010764LG $ROG $RHHBY
Roche
@Roche
May 27
Mass spectrometry is transforming diagnostics, but simply having the tech isn't enough. The real breakthrough comes from seamlessly integrating it into the lab's entire workflow. Hear from Roche’s Benjamin Lilienfield about the value of integration to healthcare labs.
00:00